According to CTI BioPharma 's latest financial reports and stock price the company's current number of shares outstanding is 131,566,000. At the end of 2023 the company had 131,566,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.13 B | 2.44% |
2022 | 0.12 B | 31.5% |
2021 | 97.66 M | 30.85% |
2020 | 74.64 M | 28.75% |
2019 | 57.97 M | 0.01% |
2018 | 57.96 M | 35.13% |
2017 | 42.89 M | -84.7% |
2016 | 0.28 B | 23.15% |
2015 | 0.22 B | 40.34% |
2014 | 0.16 B | 46.14% |
2013 | 0.11 B | 109.74% |
2012 | 52.92 M | -71.39% |
2011 | 0.18 B | -74% |
2010 | 0.71 B | 34.97% |
2009 | 0.52 B | 3035.89% |
2008 | 16.81 M | 248.94% |
2007 | 4.81 M | -95.68% |
2006 | 0.11 B | 75.66% |
2005 | 63.5 M | 13% |
2004 | 56.19 M | 67.25% |
2003 | 33.59 M | 2.75% |
2002 | 32.69 M | -2.92% |
2001 | 33.68 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,062,000,000 | 1,467.27% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 949,379,000 | 621.60% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 306.64% | ๐บ๐ธ USA |
Baxter BAX | 507,000,000 | 285.36% | ๐บ๐ธ USA |
Incyte INCY | 224,078,000 | 70.32% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 1,463.47% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 752.04% | ๐ฎ๐ฑ Israel |